Avricore Health (AVCRF) Total Current Liabilities (2011 - 2026)
Avricore Health (AVCRF) posted quarterly Total Current Liabilities of $283782.1 for Q1 2026, up 117.69% year-over-year from $130363.1 in Q1 2025, and up 128.01% quarter-over-quarter from $124458.2 in Q4 2025.
Avricore Health (AVCRF) Total Current Liabilities (2011 - 2026) Analysis & Trends
Avricore Health (AVCRF) has reported Total Current Liabilities for 16 consecutive years, with $283782.1 the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities rose 117.69% year-over-year to $283782.1; the TTM figure through Mar 2026 stood at $283782.1 (up 117.69% YoY), while the FY2025 annual figure was $124221.3, down 48.59% from the prior year.
- Total Current Liabilities improved to $283782.1 in Q1 2026 per AVCRF's latest filing, from $124458.2 in the prior quarter.
- Across five years, Total Current Liabilities topped out at $482242.6 in Q3 2023 and bottomed at $26075.3 in Q3 2025.
- Historically, Total Current Liabilities has averaged $249058.2 across 5 years, with a median of $265351.1 in 2023.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 564.93% — and 2025, when it tumbled 93.38%.
- Avricore Health's Total Current Liabilities stood at $445626.5 in 2022, then declined by 12.77% to $388729.4 in 2023, then tumbled by 39.08% to $236815.1 in 2024, then tumbled by 47.44% to $124458.2 in 2025, then jumped by 128.01% to $283782.1 in 2026.
- Business Quant data shows AVCRF's Total Current Liabilities at $283782.1 in Q1 2026, $124458.2 in Q4 2025, and $26075.3 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 15.07 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 8.11 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 1.29 Bn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 2.27 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 8.82 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 558.26 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 1.58 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 1.20 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 1.79 Bn |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 283,782.06 |
| Dec 31, 2025 | 124,458.21 |
| Sep 30, 2025 | 26,075.30 |
| Jun 30, 2025 | 33,592.83 |
| Mar 31, 2025 | 130,363.11 |
| Dec 31, 2024 | 236,815.07 |
| Sep 30, 2024 | 393,724.44 |
| Jun 30, 2024 | 251,319.43 |
| Mar 31, 2024 | 428,548.11 |
| Dec 31, 2023 | 388,729.42 |
| Sep 30, 2023 | 482,242.56 |
| Jun 30, 2023 | 265,351.15 |
| Mar 31, 2023 | 302,155.61 |
| Dec 31, 2022 | 445,626.45 |
| Sep 30, 2022 | 289,077.14 |
| Jun 30, 2022 | 99,644.21 |
| Mar 31, 2022 | 52,483.54 |
| Dec 31, 2021 | 67,018.65 |
| Sep 30, 2021 | 157,190.56 |
| Jun 30, 2021 | 149,556.39 |